Head and Neck Pathology

, Volume 11, Issue 1, pp 3–15 | Cite as

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base

Original Paper
Part of the following topical collections:
  1. World Health Organization Classification Update

Abstract

The sinonasal tract remains an epicenter of a diverse array of neoplasia. This paper discusses changes to the WHO classification system of tumors involving this area. In particular, seromucinous hamartoma, NUT carcinoma, biphenotypic sinonasal sarcoma, HPV-related carcinoma with adenoid cystic features, SMARCB1-deficient carcinoma, and renal cell-like adenocarcinoma are discussed.

Keywords

Nasal Sinonasal Sinus Human papillomavirus WHO NUT carcinoma Seromucinous hamartoma Biphenotypical sinonasal sarcoma Adenoid cystic INI1 

Notes

Compliance with Ethical Standards

Disclosure

Drs. Bishop and Stelow have no conflict of interest.

Research Involving Animal and Human Rights

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Lewis JS Jr. Sinonasal squamous cell carcinoma: a review with emphasis on emerging histologic subtypes and the role of human papillomavirus. Head Neck Pathol. 2016;10:60–7.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Bishop JA, Guo TW, Smith DF, Wang H, Ogawa T, Pai SI, Westra WH. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37:185–92.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29:1367–72.CrossRefPubMedGoogle Scholar
  4. 4.
    Larque AB, Hakim S, Ordi J, Nadal A, Diaz A, del Pino M, Marimon L, Alobid I, Cardesa A, Alos L. High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas. Mod Pathol. 2014;27:343–51.PubMedGoogle Scholar
  5. 5.
    Jo VY, Mills SE, Stoler MH, Stelow EB. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33:1720–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Rytkonen AE, Hirvikoski PP, Salo TA. Lymphoepithelial carcinoma: two case reports and a systematic review of oral and sinonasal cases. Head Neck Pathol. 2011;5:327–34.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol. 1986;10:192–202.CrossRefPubMedGoogle Scholar
  8. 8.
    Batsakis JG, Mackay B, Ordonez NG. Enteric-type adenocarcinoma of the nasal cavity. An electron microscopic and immunocytochemical study. Cancer. 1984;54:855–60.CrossRefPubMedGoogle Scholar
  9. 9.
    Cathro HP, Mills SE. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2. Am J Surg Pathol. 2004;28:1026–32.CrossRefPubMedGoogle Scholar
  10. 10.
    Acheson ED, Cowdell RH, Hadfield E, Macbeth RG. Nasal cancer in woodworkers in the furniture industry. Br Med J. 1968;2:587–96.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Hadfield EH. A study of adenocarcinoma of the paranasal sinuses in woodworkers in the furniture industry. Ann R Coll Surg Engl. 1970;46:301–19.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Hadfield EH, Macbeth RG. Adenocarcinoma of ethmoids in furniture workers. Ann Otol Rhinol Laryngol. 1971;80:699–703.CrossRefPubMedGoogle Scholar
  13. 13.
    Heffner DK, Hyams VJ, Hauck KW, Lingeman C. Low-grade adenocarcinoma of the nasal cavity and paranasal sinuses. Cancer. 1982;50:312–22.CrossRefPubMedGoogle Scholar
  14. 14.
    Jo VY, Mills SE, Cathro HP, Carlson DL, Stelow EB. Low-grade sinonasal adenocarcinomas: the association with and distinction from respiratory epithelial adenomatoid hamartomas and other glandular lesions. Am J Surg Pathol. 2009;33:401–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Kleinsasser O. Terminal tubulus adenocarcinoma of the nasal seromucous glands. A specific entity. Arch Otorhinolaryngol. 1985;241:183–93.CrossRefPubMedGoogle Scholar
  16. 16.
    Stelow EB, Mills SE, Jo VY, Carlson DL. Adenocarcinoma of the upper aerodigestive tract. Adv Anat Pathol. 2010;17:262–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Stelow EB, Jo VY, Mills SE, Carlson DL: A histologic and immunohistochemical stduy of high-grade non-intestinal sinonasal adenocarcinomas. Am J Surg Pathol 2011;35:971–80 In Press.CrossRefGoogle Scholar
  18. 18.
    Perez-Ordonez B, Caruana SM, Huvos AG, Shah JP. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. Hum Pathol. 1998;29:826–32.CrossRefPubMedGoogle Scholar
  19. 19.
    Weinreb I, Perez-Ordonez B. Non-small cell neuroendocrine carcinoma of the sinonasal tract and nasopharynx. Report of 2 cases and review of the literature. Head Neck Pathol. 2007;1:21–6.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Franchi A, Rocchetta D, Palomba A, Degli Innocenti DR, Castiglione F, Spinelli G. Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with immunohistochemical and molecular characterization. Head Neck Pathol. 2015;9:107–13.CrossRefPubMedGoogle Scholar
  21. 21.
    Thompson ED, Stelow EB, Mills SE, Westra WH, Bishop JA. Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 cases with an emphasis on HPV status. Am J Surg Pathol. 2016;40:471–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Wang CP, Hsieh CY, Chang YL, Lou PJ, Yang TL, Ting LL, Ko JY. Postirradiated neuroendocrine carcinoma of the sinonasal tract. Laryngoscope. 2008;118:804–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Frierson HF Jr, Mills SE, Fechner RE, Taxy JB, Levine PA. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol. 1986;10:771–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Heffner DK, Hyams VJ. Teratocarcinosarcoma (malignant teratoma?) of the nasal cavity and paranasal sinuses: a clinicopathologic study of 20 cases. Cancer. 1984;53:2140–54.CrossRefPubMedGoogle Scholar
  25. 25.
    Salem F, Rosenblum MK, Jhanwar SC, Kancherla P, Ghossein RA, Carlson DL. Teratocarcinosarcoma of the nasal cavity and paranasal sinuses: report of 3 cases with assessment for chromosome 12p status. Hum Pathol. 2008;39:605–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Kumar S, Perlman E, Pack S, Davis M, Zhang H, Meltzer P, Tsokos M. Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing’s sarcoma family. Hum Pathol. 1999;30:1356–60.CrossRefPubMedGoogle Scholar
  27. 27.
    Taxy JB, Bharani NK, Mills SE, Frierson HF Jr, Gould VE. The spectrum of olfactory neural tumors. A light-microscopic immunohistochemical and ultrastructural analysis. Am J Surg Pathol. 1986;10:687–95.CrossRefPubMedGoogle Scholar
  28. 28.
    Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015;39:1267–74.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Crane GM, Duffield AS. Hematolymphoid lesions of the sinonasal tract. Semin Diagn Pathol. 2016;33:71–80.CrossRefPubMedGoogle Scholar
  30. 30.
    Kreisel FH. Hematolymphoid lesions of the sinonasal tract. Head and Neck Pathol. 2016;10:109–17.CrossRefGoogle Scholar
  31. 31.
    Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003;27:737–49.CrossRefPubMedGoogle Scholar
  32. 32.
    Lasota J, Felisiak-Golabek A, Aly FZ, Wang ZF, Thompson LD, Miettinen M. Nuclear expression and gain-of-function beta-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker. Mod Pathol. 2015;28:715–20.CrossRefPubMedGoogle Scholar
  33. 33.
    Weinreb I, Gnepp DR, Laver NM, Hoschar AP, Hunt JL, Seethala RR, Barnes EL, Chetty R, Perez-Ordonez B. Seromucinous hamartomas: a clinicopathological study of a sinonasal glandular lesion lacking myoepithelial cells. Histopathology. 2009;54:205–13.CrossRefPubMedGoogle Scholar
  34. 34.
    Ozolek JA, Barnes EL, Hunt JL. Basal/myoepithelial cells in chronic sinusitis, respiratory epithelial adenomatoid hamartoma, inverted papilloma, and intestinal-type and nonintestinal-type sinonasal adenocarcinoma: an immunohistochemical study. Arch Pathol Lab Med. 2007;131:530–7.PubMedGoogle Scholar
  35. 35.
    Jo VY, Mills SE, Cathro HP, Carlson DL, Stelow EB. Low-grade sinonasal adenocarcinomas: the association with and distinction from respiratory epithelial adenomatoid hamartomas and other glandular lesions. Am J Surg Pathol 2008; 33:401–408Google Scholar
  36. 36.
    Ambrosini-Spaltro A, Morandi L, Spagnolo DV, Cavazza A, Brisigotti M, Damiani S, Jain S, Eusebi V. Nasal seromucinous hamartoma (microglandular adenosis of the nose): a morphological and molecular study of five cases. Virchows Arch. 2010;457:727–34.CrossRefPubMedGoogle Scholar
  37. 37.
    Kees UR, Mulcahy MT, Willoughby ML. Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am J Pediatric Hematol. 1991;13:459–64.CrossRefGoogle Scholar
  38. 38.
    Kubonishi I, Takehara N, Iwata J, Sonobe H, Ohtsuki Y, Abe T, Miyoshi I. Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res. 1991;51:3327–8.PubMedGoogle Scholar
  39. 39.
    French C. NUT midline carcinoma. Nature reviews Cancer. 2014;14:149–50.CrossRefPubMedGoogle Scholar
  40. 40.
    French CA. The importance of diagnosing NUT midline carcinoma. Head Neck Pathol. 2013;7:11–6.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Stelow EB. A review of NUT midline carcinoma. Head Neck Pathol. 2011;5:31–5.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Luer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012;18:5773–9.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Stelow EB, Bellizzi AM, Taneja K, Mills SE, Legallo RD, Kutok JL, Aster JC, French CA. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008;32:828–34.CrossRefPubMedGoogle Scholar
  44. 44.
    Solomon LW, Magliocca KR, Cohen C, Muller S. Retrospective analysis of nuclear protein in testis (NUT) midline carcinoma in the upper aerodigestive tract and mediastinum. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;119:213–220Google Scholar
  45. 45.
    Bishop JA, Westra WH. NUT midline carcinomas of the sinonasal tract. Am J Surg Pathol. 2012;36:1216–21.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Fang W, French CA, Cameron MJ, Han Y, Liu H. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract. Int J Surg Pathol. 2013;21:102–10.CrossRefPubMedGoogle Scholar
  47. 47.
    Bishop JA, French CA, Ali SZ. Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients. Cancer Cytopathol. 2016;124:901–908CrossRefGoogle Scholar
  48. 48.
    Bellizzi AM, Bruzzi C, French CA, Stelow EB. The cytologic features of NUT midline carcinoma. Cancer. 2009;117:508–15.PubMedGoogle Scholar
  49. 49.
    French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, Kutok JL, Toretsky JA, Tadavarthy AK, Kees UR, Fletcher JA, Aster JC. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008;27:2237–42.CrossRefPubMedGoogle Scholar
  50. 50.
    Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, Hong SM, Schwartz BE, Cameron MJ, Rubin MA, Chang MC, Aster JC, French CA. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33:984–91.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    French CA. Pathogenesis of NUT midline carcinoma. Annu Rev Pathol. 2012;7:247–65.CrossRefPubMedGoogle Scholar
  52. 52.
    Lewis JT, Oliveira AM, Nascimento AG, Schembri-Wismayer D, Moore EA, Olsen KD, Garcia JG, Lonzo ML, Lewis JE. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol. 2012;36:517–25.CrossRefPubMedGoogle Scholar
  53. 53.
    Huang SC, Ghossein RA, Bishop JA, Zhang L, Chen TC, Huang HY, Antonescu CR. Novel PAX3-NCOA1 fusions in biphenotypic sinonasal sarcoma with focal rhabdomyoblastic differentiation. Am J Surg Pathol. 2016;40:51–9.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Wang X, Bledsoe KL, Graham RP, Asmann YW, Viswanatha DS, Lewis JE, Lewis JT, Chou MM, Yaszemski MJ, Jen J, Westendorf JJ, Oliveira AM. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet. 2014;46:666–8.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Powers KA, Han LM, Chiu AG, Aly FZ. Low-grade sinonasal sarcoma with neural and myogenic features-diagnostic challenge and pathogenic insight. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:e265–e9.CrossRefPubMedGoogle Scholar
  56. 56.
    Rooper LM, Huang SC, Antonescu CR, Westra WH, Bishop JA. Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear beta-catenin positivity and absence of SOX10 expression. Hum Pathol. 2016;55:44–50.CrossRefPubMedGoogle Scholar
  57. 57.
    Wong WJ, Lauria A, Hornick JL, Xiao S, Fletcher JA, Marino-Enriquez A. Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma. Genes Chromosomes Cancer. 2016;55:25–9.CrossRefPubMedGoogle Scholar
  58. 58.
    Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35:1343–50.CrossRefPubMedGoogle Scholar
  59. 59.
    Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116:2166–73.PubMedGoogle Scholar
  60. 60.
    Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36:1874–82.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Poling JS, Ma XJ, Bui S, Luo Y, Li R, Koch WM, Westra WH. Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue. Oral Oncol. 2014;50:306–10.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Lewis JS Jr, Ukpo OC, Ma XJ, Flanagan JJ, Luo Y, Thorstad WL, Chernock RD. Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas–a tissue microarray study utilizing E6/E7 mRNA in situ hybridization. Histopathology. 2012;60:982–91.CrossRefPubMedGoogle Scholar
  63. 63.
    Alos L, Moyano S, Nadal A, Alobid I, Blanch JL, Ayala E, Lloveras B, Quint W, Cardesa A, Ordi J. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer. 2009;115:2701–9.CrossRefPubMedGoogle Scholar
  64. 64.
    Bishop JA, Ogawa T, Stelow EB, Moskaluk CA, Koch WM, Pai SI, Westra WH. Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. Am J Surg Pathol. 2013;37:836–44.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Hwang SJ, Ok S, Lee HM, Lee E, Park IH. Human papillomavirus-related carcinoma with adenoid cystic-like features of the inferior turbinate: a case report. Auris Nasus Larynx. 2015;42:53–5.CrossRefPubMedGoogle Scholar
  66. 66.
    Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, Weissman B, Smith M. The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res. 2002;62:323–8.PubMedGoogle Scholar
  67. 67.
    Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59:74–9.PubMedGoogle Scholar
  68. 68.
    Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg. 1996;85:56–65.CrossRefPubMedGoogle Scholar
  69. 69.
    Biegel JA, Burk CD, Parmiter AH, Emanuel BS. Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor. Genes Chromosomes Cancer. 1992;5:104–8.CrossRefPubMedGoogle Scholar
  70. 70.
    Biegel JA, Rorke LB, Emanuel BS. Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. N Engl J Med. 1989;321:906.PubMedGoogle Scholar
  71. 71.
    Shashi V, Lovell MA, von Kap-herr C, Waldron P, Golden WL. Malignant rhabdoid tumor of the kidney: involvement of chromosome 22. Genes Chromosomes Cancer. 1994;10:49–54.CrossRefPubMedGoogle Scholar
  72. 72.
    Schofield DE, Beckwith JB, Sklar J. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors. Genes Chromosomes Cancer. 1996;15:10–7.CrossRefPubMedGoogle Scholar
  73. 73.
    Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 2009;33:542–50.CrossRefPubMedGoogle Scholar
  74. 74.
    Modena P, Lualdi E, Facchinetti F, Galli L, Teixeira MR, Pilotti S, Sozzi G. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 2005;65:4012–9.CrossRefPubMedGoogle Scholar
  75. 75.
    Le Loarer F, Zhang L, Fletcher CD, Ribeiro A, Singer S, Italiano A, Neuville A, Houlier A, Chibon F, Coindre JM, Antonescu CR. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material. Genes Chromosomes Cancer 2014.Google Scholar
  76. 76.
    Cheng JX, Tretiakova M, Gong C, Mandal S, Krausz T, Taxy JB. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008;21:647–52.CrossRefPubMedGoogle Scholar
  77. 77.
    Gleason BC, Fletcher CD. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am J Surg Pathol. 2007;31:1813–24.CrossRefPubMedGoogle Scholar
  78. 78.
    Kohashi K, Oda Y, Yamamoto H, Tamiya S, Oshiro Y, Izumi T, Taguchi T, Tsuneyoshi M. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Am J Surg Pathol. 2008;32:1168–74.CrossRefPubMedGoogle Scholar
  79. 79.
    Agaimy A, Rau TT, Hartmann A, Stoehr R. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. Am J Surg Pathol 2014;38:910–920Google Scholar
  80. 80.
    Bishop JA, Antonescu CR, Westra WH. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract. Am J Surg Pathol. 2014;38:1282–9.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Agaimy A, Koch M, Lell M, Semrau S, Dudek W, Wachter DL, Knoll A, Iro H, Haller F, Hartmann A. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. Am J Surg Pathol. 2014;38:1274–81.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Bell D, Hanna EY, Agaimy A, Weissferdt A. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Archiv 2015;467:649–656CrossRefGoogle Scholar
  83. 83.
    Zur KB, Brandwein M, Wang B, Som P, Gordon R, Urken ML. Primary description of a new entity, renal cell-like carcinoma of the nasal cavity: van Meegeren in the house of Vermeer. Arch Otolaryngol Head Neck Surg. 2002;128:441–7.CrossRefPubMedGoogle Scholar
  84. 84.
    Storck K, Hadi UM, Simpson R, Ramer M, Brandwein-Gensler M. Sinonasal renal cell-like adenocarcinoma: a report on four patients. Head Neck Pathol. 2008;2:75–80.CrossRefPubMedPubMedCentralGoogle Scholar
  85. 85.
    Moh’d Hadi U, Kahwaji GJ, Mufarrij AA, Tawil A, Noureddine B. Low grade primary clear cell carcinoma of the sinonasal tract. Rhinology. 2002;40:44–7.PubMedGoogle Scholar
  86. 86.
    Brandwein-Gensler M, Wei S. Envisioning the next WHO head and neck classification. Head Neck Pathol. 2014;8:1–15.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Shen T, Shi Q, Velosa C, Bai S, Thompson L, Simpson R, Wei S, Brandwein-Gensler M. Sinonasal renal cell-like adenocarcinomas: robust carbonic anhydrase expression. Hum Pathol. 2015;46:1598–606.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Department of Pathology, Anatomic PathologyUniversity of Virginia Health SystemCharlottesvilleUSA
  2. 2.Department of PathologyJohns Hopkins UniversityBaltimoreUSA

Personalised recommendations